Beta Bionics revenue was $65.12M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $20.4M, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BBNX annual revenue was $65.1M, with 442.9% growth year-over-year.
BBNX past revenue growth
How has BBNX's revenue growth performed historically?
Beta Bionics (NASDAQ: BBNX) reported Q4 2024 revenue of $20.44 million up 144.79% year over year. In the same quarter last year, Beta Bionics's revenue was $8.35 million.
What was Beta Bionics's revenue in 2024?
Beta Bionics's annual revenue for the twelve months ending Dec 31, 2024 was $65.12 million, a 442.93% increase year over year.
How much does Beta Bionics make in a day?
Based on Beta Bionics annual revenue for the past two years, BBNX makes an average of $105,642.47 per day.
What was Beta Bionics's annual revenue growth in the past year?
As of Q2 2025, Beta Bionics's revenue has grown 442.93% year over year. This is 432.4 percentage points higher than the US Medical Devices industry revenue growth rate of 10.53%. Beta Bionics's revenue in the past year totaled $65.12 million.
How much does Beta Bionics make in a year?
Beta Bionics's revenue by year for the past two years is:
Beta Bionics's revenue for the twelve months ending Dec 31, 2024 was $65.12 million, a 442.93% increase year over year.
Beta Bionics's annual revenue for Dec 31, 2023 was $12.00 million, a 6,601.12% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.